NCT06524323View on ClinicalTrials.gov

A Randomized, Double-blinded, Self-controlled Clinical Study of Intralesional Injection of 5-fluorouracil Plus Triamcinolone for the Treatment of Refractory Nodular Prurigo

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Nodular Prurigo
Interventions
DRUG

5-fluorouracil Injection

The mixture contains 2mL of triamcinolone acetonide injection and 4mL of 5-fluorouracil injection, which is diluted with saline to 10mL.

DRUG

Triamcinolone Acetonide

The mixture contains 2mL of triamcinolone acetonide injection which is diluted with saline to 10mL.

Trial Locations (1)

310000

2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT06524323 - A Randomized, Double-blinded, Self-controlled Clinical Study of Intralesional Injection of 5-fluorouracil Plus Triamcinolone for the Treatment of Refractory Nodular Prurigo | Biotech Hunter | Biotech Hunter